Telo Genomics
Toronto
About Telo Genomics
Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jan 2026)
- Ticker: cve:TELO
- Website: telodx.com
- Phone: +1 416-673-8487
Industries & Categories
Biotechnology, Oncology
Social Profiles
Canonical: https://fsome.com/organization/telo-genomics-49201 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.